Product
TR004
1 clinical trial
1 indication
Indication
Crohn's DiseaseClinical trial
A First in Human Feasibility Study of T Regulatory Cells (TR004) for Inflammatory Bowel Disease Using (ex Vivo) Treg ExpansionStatus: Recruiting, Estimated PCD: 2024-03-31